Performance of Immunoassays for Ca 19-9, Ca 15-3 and Ca 125 Tumour Markers Evaluated from an International Quality Assessment Survey

Clinical Chemistry and Laboratory Medicine

Volumn 34, Issue 2, 1996, Pages 145-165

  Pilo, Alessandro ^a   Zitccheli, Gian Carlo ^a   Chiesa, Maria Rosa ^a   Cohen, Richard ^b   Bizollon, Charles Albert ^b  

^a CNR   (Italy)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; TUMOR MARKER;

ACCURACY; ARTICLE; AUTOMATION; CONTROLLED STUDY; HUMAN; IMMUNOASSAY; METHODOLOGY; PRIORITY JOURNAL; QUALITY CONTROL;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CA-125 ANTIGEN; CA-15-3 ANTIGEN; CA-19-9 ANTIGEN; EVALUATION STUDIES; HUMANS; IMMUNOASSAY; INTERNATIONAL COOPERATION; QUALITY CONTROL; REAGENT KITS, DIAGNOSTIC; TUMOR MARKERS, BIOLOGICAL;

EID: 0030042947     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.1996.34.2.145     Document Type: Article

References (12)

1. Bombardieri E, Seregni E, Crippa F, Buraggi GL. An update on the biology of mucins as tumor markers. In: Up dating on tumor markers in tissues and in biological fluids. Torino: Edizioni Minerva Medica, 1993: 477-486.
2. Bon GG, Kenemans P, Van Kamp GJ, Yedema CA, Hilgers J. Review on the clinical value of polymorphic epithelial mucin tumor markers for the management of carcinoma patients. J Nucl Med All Sci 1990; Suppl 34: 151-162.
3. Pilo A, Zucchelli GC, Masini S, Torre GC, Ballestra AM. Progress report on an external quality assessment program for immunoassays of tumor markers. J Nucl Med All Sci 1990; Suppl 34: 75-82.
4. Zucchelli GC, Pilo A, Chiesa MR, Masini S, Prontera C, Cianetti A. The CNR External Quality Assessment program for tumor markers. In: Up dating on tumor markers in tissues and in biological fluids. Torino: Edizioni Minerva Medica, 1993: 129-140.
5. Cohen R, Zucchelli GC, Fraysse M, Pilo A, Rigault MY, Grillet S, Bizollon C.A.: “Oncocheck: an international external quality assessment scheme for immunoassays of tumor markers”. Nucl Med Biol 1994; 21(3):483-493.
6. Seth J, Sturgeon CM, Al Sadie R, Manning I, Ellis AR. External quality assessment of immunoassay of peptide hormones and tumour markers: principles and practice. Ann 1st Super Sanita 1991; 27: 443-452.
7. Cohen R, Bizollon C.A. Immunoassay external quality assessment schemes in France. Ann 1st Super Sanita 1991; 27: 503-510.
8. Pilo A, Zucchelli GC, Chiesa MR, Masini S, Clerico A. The CNR external quality assessment program for immunoassays: statistical analysis and reports for participants: Ann 1st Super Sanita 1991; 27: 469-478.
9. McDonough F, Munson PJ, Rodbard DA. A computerized approach to statistical quality control for RIA in clinical chemistry laboratory. Comput Prog Biomed 1977; 7: 179-185.
10. Pilo A, Zucchelli GC, Chiesa MR, Bolelli GF, Albertini A. Components of variance analysis of data produced in a national quality control survey of radioimmunoassay of T3, T4, TSH, prolactin and progesterone. Clin Chem 1986; 32: 171-175.
11. Hammarstroem S. Chemistry and immunology of CEA, CA 19-9 and CA 50. In: Holmgren J, editor. Tumor markers antigens. Studentlitteratur, Lund 1985: 34-51.
12. Zucchelli GC, Pilo A, Chiesa MR, Cohen R, Bizollon CA. Growing use of nonisotopic CA 19-9 immunoassays increases between-laboratory variability. Clin Chem 1993; 39: 909-11.